Frankfurt
06.06.25 | 08:02
0,061 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,061 | 0,084 | 06.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.05. | Ventripoint Diagnostics Ltd.: Ventripoint to Exhibit at the 58th Annual Meeting of the Association for European Paediatric and Congenital Cardiology | 1 | TheNewswire | ||
| 30.04. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Gall to business advisory board | 1 | Stockwatch | ||
| 30.04. | Ventripoint Diagnostics Ltd.: Ventripoint Expands Advisory Board with addition of Ultrasound AI Executive | 1 | TheNewswire | ||
| 11.04. | Ventripoint Diagnostics Ltd (2): Ventripoint to hold shareholder teleconference April 15 | 1 | Stockwatch | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 10.04. | Ventripoint Diagnostics Ltd.: Ventripoint Provides Corporate Update and Announces Shareholder Teleconference | 1 | TheNewswire | ||
| 08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint $500,000 debenture private placement | 1 | Stockwatch | ||
| 08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Coutin to oversee clinical affairs | 2 | Stockwatch | ||
| 08.04. | Ventripoint Diagnostics Ltd.: Ventripoint Appoints Nicolas Coutin to Oversee Clinical Affairs | - | TheNewswire | ||
| 08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics warrants extended | 1 | Stockwatch | ||
| 04.04. | Ventripoint Diagnostics Ltd (2): Ventripoint applies to extend 2.84 million warrants | 1 | Stockwatch | ||
| 03.04. | Ventripoint Diagnostics Ltd.: Ventripoint Makes Application to Amend Warrants | 1 | TheNewswire | ||
| 24.03. | Ventripoint Diagnostics Ltd (2): Ventripoint publishes white paper on AI use | 1 | Stockwatch | ||
| 24.03. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Publishes Whitepaper on the Use of AI in Whole-Heart Analysis | 4 | TheNewswire | ||
| 22.03. | Ventripoint Diagnostics Ltd (2): Ventripoint 5.97-million-share private placement | 3 | Stockwatch | ||
| 21.03. | Ventripoint Diagnostics Ltd (2): Ventripoint closes $500,000 private placement | 1 | Stockwatch | ||
| 21.03. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of $500,000 Non-Brokered Convertible Debenture Unit Private Placement | 4 | TheNewswire | ||
| 14.03. | Ventripoint Diagnostics Ltd (2): Ventripoint arranges $500,000 private placement | 4 | Stockwatch | ||
| 14.03. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement | 2 | TheNewswire | ||
| 06.03. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 83,864 shares for debt | 3 | Stockwatch | ||
| 28.02. | Ventripoint Diagnostics Ltd (2): Ventripoint receives FDA clearance for VMS+ 4.0 system | 3 | Stockwatch |
1 2 3 Weiter >>
45 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 0,800 | +8,40 % | Ascendiant Capital raises Atossa Genetics stock price target to $7.50 | ||
| TANDEM DIABETES | 18,235 | +0,03 % | Do You Believe in the Long-Term Growth Potential of Tandem Diabetes Care (TNDM)? | ||
| NETRAMARK | 0,875 | -1,13 % | Rückenwind für diese Aktien - Eli Lilly, NetraMark, Bayer | Die wirtschaftliche Unsicherheit an den Aktienmärkten ist nach wie vor hoch. Die neue US-amerikanische Zollpolitik unter Trump ist unberechenbar und was gestern noch Gültigkeit hatte, kann nach einem... ► Artikel lesen | |
| VERU | 0,525 | -3,40 % | Veru Inc.: Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide ... | --Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial... ► Artikel lesen | |
| MOLINA HEALTHCARE | 258,90 | -0,58 % | Beyond The Numbers: 7 Analysts Discuss Molina Healthcare Stock | ||
| CLOVER HEALTH INVESTMENTS | 2,645 | -1,34 % | Clover Health Investments, Corp.: Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage | WILMINGTON, Del., April 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), today announced the appointment of Dr. Shelly Gupta... ► Artikel lesen | |
| COGNETIVITY NEUROSCIENCES | 0,015 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 02.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.06.2025ISIN NameCA19243C1005 COGNETIVITY... ► Artikel lesen | |
| SHL TELEMEDICINE | - | - | SHL TELEMEDICINE LTD - 6-K, Report of foreign issuer | ||
| SOMNIGROUP INTERNATIONAL | 56,00 | -0,88 % | $100 Invested In Somnigroup International 15 Years Ago Would Be Worth This Much Today | ||
| SINTX TECHNOLOGIES | 2,840 | +1,79 % | SINTX Technologies, Inc.: SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market | SALT LAKE CITY, Utah, May 22, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a leader in advanced ceramics for medical device and other technical applications... ► Artikel lesen | |
| SEMLER SCIENTIFIC | 29,200 | +0,69 % | Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP | ||
| NEURONETICS | 3,390 | +3,99 % | Neuronetics to join Russell 3000 and Russell 2000 indexes | ||
| RELEVIUM | 0,013 | -100,00 % | Relevium Technologies Inc.: Relevium Technologies to be delisted from NEX | ||
| SIEMENS HEALTHINEERS | 46,650 | +0,26 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 44,290 | +0,11 % | DAX-Check LIVE: Bilfinger, Cancom, Delivery Hero, Fresenius, Gerresheimer, Rheinmetall im Fokus | Der DAX hat den gestrigen Handelstag mit leichten Verlusten beendet. Der deutsche Leitindex schloss 0,28 Prozent tiefer bei 23.930 Punkten. Zwar konnte er sich am Nachmittag vom Tagestief bei 23.740... ► Artikel lesen |
VENTRIPOINT DIAGNOSTICS LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,061 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.